David S. Silberstein - 04 Nov 2021 Form 4 Insider Report for Lantern Pharma Inc. (LTRN)

Role
Director
Signature
/s/ David S. Silberstein
Issuer symbol
LTRN
Transactions as of
04 Nov 2021
Net transactions value
$0
Form type
4
Filing time
08 Nov 2021, 15:05:40 UTC
Next filing
17 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LTRN Stock Option (Right to Buy) Award $0 +3,200 $0.000000 3,200 04 Nov 2021 Common Stock 3,200 $10.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing upon December 4, 2021.